Literature DB >> 620087

Differences in the terminal steps of complement lysis of normal and paroxysmal nocturnal hemoglobinuria red cells.

T A Rouault, W F Rosse, S Bell, J Shelburne.   

Abstract

The number of microscopically visible lesions produced on the membrane for a given degree of lysis on normal cells as on PNH cells. Since complement lesions were not formed until C8 or C9 was incorporated into the complement sequence, the results suggest that increased lysis of red cells in PNH is due at least in part to more efficient penetration of the PNH membrane by the terminal lytic sequence of complement. Furthermore, the efficiency of the terminal lytic sequence in the lysis of PNH cells when complement was activated by the alternative pathway and the classical pathway was analyzed. There was no significant difference (p less than 0.01) in the number of lesion present at an equivalent degree of lysis when initiated by antibody, cobra venom factor, or acidification. Thus, the efficiency of the terminal lytic sequence does not vary with different modes of activation.

Entities:  

Mesh:

Substances:

Year:  1978        PMID: 620087

Source DB:  PubMed          Journal:  Blood        ISSN: 0006-4971            Impact factor:   22.113


  10 in total

Review 1.  [Paroxysmal nocturnal hemoglobinuria].

Authors:  P Blaas; S Weber; G M Hänsch; H H Peter
Journal:  Klin Wochenschr       Date:  1990-03-05

2.  Complement-mediated lysis of pigeon erythrocyte ghosts analysed by flow cytometry. Evidence for the involvement of a 'threshold' phenomenon.

Authors:  S W Edwards; B P Morgan; T G Hoy; J P Luzio; A K Campbell
Journal:  Biochem J       Date:  1983-10-15       Impact factor: 3.857

Review 3.  The role of complement in immune clearance of blood cells.

Authors:  U E Nydegger; M D Kazatchkine
Journal:  Springer Semin Immunopathol       Date:  1983

Review 4.  Is the membrane attack complex of complement an enzyme?

Authors:  M D Boyle
Journal:  Mol Cell Biochem       Date:  1984       Impact factor: 3.396

5.  Paroxysmal nocturnal hemoglobinuria--present status and future prospects.

Authors:  W F Rosse
Journal:  West J Med       Date:  1980-03

6.  Complement lysis of human erythrocytes. Differeing susceptibility of two types of paroxysmal nocturnal hemoglobinuria cells to C5b-9.

Authors:  C H Packman; S I Rosenfeld; D E Jenkins; P A Thiem; J P Leddy
Journal:  J Clin Invest       Date:  1979-08       Impact factor: 14.808

7.  On the lysis of paroxysmal nocturnal hemoglobinuria erythrocytes by complement: dual role of C3b.

Authors:  C M Jones; M L Shin; M M Mayer
Journal:  Blut       Date:  1982-10

8.  Inhibition of the lytic action of cell-bound terminal complement components by human high density lipoproteins and apoproteins.

Authors:  S I Rosenfeld; C H Packman; J P Leddy
Journal:  J Clin Invest       Date:  1983-04       Impact factor: 14.808

9.  Interactions of the platelets in paroxysmal nocturnal hemoglobinuria with complement. Relationship to defects in the regulation of complement and to platelet survival in vivo.

Authors:  D V Devine; R S Siegel; W F Rosse
Journal:  J Clin Invest       Date:  1987-01       Impact factor: 14.808

10.  Acute myeloblastic leukemia in paroxysmal nocturnal hemoglobinuria. Evidence of evolution from the abnormal paroxysmal nocturnal hemoglobinuria clone.

Authors:  D V Devine; W L Gluck; W F Rosse; J B Weinberg
Journal:  J Clin Invest       Date:  1987-01       Impact factor: 14.808

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.